Investigating and evaluating the newest products and mechanisms for promising therapies.
Medical Consultation
The need was presented to
adequately portray the mechanism of action for this Novartis drug
representing a new class of diabetes treatment.
Video scripts
and detailers needed to be written that could relate how this drug
differs from the other well-established diabetes medications.
The
importance of this drug had to be placed in context of the then
current medications. Study data needed to be interpreted and summarize
to the best effect for explaining the benefits of this new drug.
Concept pieces were needed for the client to review. Scientific accuracy was always the major concern.
Medical Writing
Vivaglobin a drug produced by ZLB Behring is immune globulin subcutaneous (human) biotherapy for immunodeficient patients.
Slide
kits needed to be produced that gave the full picture of the range of patients eligible for this treatment, the history of the development of immunoglobulin therapy, and finally
the Vivaglobin product features.
This also required
understanding, illustrating and explaining the variety of subcutaneous
infusion pumps that were available for patients so that they could
maintain an active lifestyle. A quick turnaround time was needed to
meet the deadline, even as more slide decks were added to complete the
needs of the upcoming meeting.
Product Testing & Evaluation
I continue to test products for the ease of use and efficiency in supporting the needs of professionals working in digital media and communication.
Most of what I produce in the form of graphics and text is published on my blogs. I try to provide an opinion on how it might fit into a clinical situation, or for knowledge workers in general.
By talking about the installation experience, and what features seem to be the most useful, the reader can get a firsthand view that is often missing in the product documentation.
Business Development
The Treo 600 was the Palm (then palmOne) smartphone that was second in its Treo line. I had been using this phone since the first model, the Treo 300, was released.
I was contacted by the company based on a recommendation by Walt Mossberg of the Wall Street Journal since I had told him I was using this phone while I was doing my ICU rotation.
This was co-produced with an e-prescribing company, DrFirst, and Epocrates. It was meant to make a strong case for the clinical use of this smartphone both by clinicians and patients. This was just the beginning of the trend to use cell phones to interface with clinical monitoring devices.